Cardiovascular

The Role of Genetic Variation in Phenotypic Variability in Loeys-Dietz Syndrome.

TL;DR

Distinct genotype-phenotype associations exist among LDS subtypes, with TGFBR1 and TGFBR2 variants associated with greater burden of aggressive vascular disease, SMAD3 variants linked to mitral valve disease, peripheral neuropathy, and osteoarthritis, and a novel association identified between TGFBR1 genotype and migraine.

Key Findings

Renal artery aneurysms were significantly more common in TGFBR1 patients compared to other LDS subtypes.

  • Renal artery aneurysms occurred in 13.8% of TGFBR1 patients (p = 0.010)
  • The study included 29 TGFBR1 patients, 33 TGFBR2 patients, and 31 SMAD3 patients
  • This finding was statistically significant across genotype groups

SMAD3 patients had significantly higher rates of mitral regurgitation compared to other LDS subtypes.

  • Mitral regurgitation occurred in 54.8% of SMAD3 patients (p = 0.04)
  • This was a statistically significant difference across the three genotype groups
  • SMAD3 patients also showed trends toward increased atrial fibrillation and osteoarthritis, though these were not statistically significant

SMAD3 patients had significantly higher rates of peripheral neuropathy compared to other LDS subtypes.

  • Peripheral neuropathy occurred in 29.0% of SMAD3 patients (p = 0.018)
  • This was a statistically significant difference across the three genotype groups
  • SMAD3 variants were also associated with trends toward osteoarthritis in addition to peripheral neuropathy

A novel association was identified between TGFBR1 variants and migraine headache.

  • Migraine was significantly more prevalent in TGFBR1 patients at 62.1% (p = 0.017)
  • The authors describe this as a 'novel association' not previously reported in LDS literature
  • This association was statistically significant across genotype groups

TGFBR1 and TGFBR2 patients demonstrated trends toward higher rates of ascending aortic aneurysm and aortic dissection compared to SMAD3 patients, though differences were not statistically significant.

  • The trends toward more aggressive vascular disease in TGFBR1 and TGFBR2 did not reach statistical significance
  • Rates of major cardiovascular surgical interventions were high and comparable across all three genotypes
  • The study was a retrospective cohort of adults evaluated between 2018 and 2024 across Mayo Clinic sites

Demographics and mortality did not differ significantly between LDS genotype groups.

  • The total cohort included 93 patients: 29 TGFBR1, 33 TGFBR2, and 31 SMAD3
  • No statistically significant differences in demographic characteristics were observed across groups
  • Mortality rates were also comparable across the three genotype groups

Patients with pathogenic, likely pathogenic, or suspicious variants in TGFBR1, TGFBR2, or SMAD3 were included in this retrospective cohort study of genetically confirmed LDS.

  • The study was conducted across Mayo Clinic sites between 2018 and 2024
  • Clinical characteristics, physical examination findings, cardiovascular and noncardiovascular manifestations, surgical interventions, and mortality were compared across genotypes
  • Categorical variables were analyzed using chi-square tests and continuous variables using parametric or nonparametric methods as appropriate
  • All patients were adults with genetically confirmed LDS

What This Means

Loeys-Dietz syndrome (LDS) is a rare inherited disorder affecting connective tissue, caused by mutations in genes involved in a signaling pathway called TGF-β. People with LDS can develop serious problems including aortic aneurysms (dangerous bulging of the main artery from the heart), heart valve disease, and issues affecting other organs. This research suggests that the specific gene mutated in a person with LDS meaningfully influences which health problems they are most likely to develop. In a study of 93 adults across Mayo Clinic sites, patients with mutations in TGFBR1 or TGFBR2 tended to have more aggressive blood vessel disease, while patients with SMAD3 mutations were more likely to experience mitral valve leakage (mitral regurgitation, found in over half of SMAD3 patients), nerve problems in their limbs (peripheral neuropathy), and joint disease (osteoarthritis). The study also identified several statistically significant findings unique to specific gene mutations. Kidney artery aneurysms were notably more common in TGFBR1 patients. Perhaps most strikingly, migraine headaches were found in over 62% of TGFBR1 patients — a connection that has not been previously reported in LDS and that the authors describe as a novel association. Despite these differences in specific complications, rates of major heart and aortic surgeries were similarly high across all three genetic groups, underscoring that all LDS subtypes carry serious cardiovascular risk. This research suggests that knowing which specific gene is mutated in a person with LDS could help doctors tailor their monitoring and management strategies more precisely — for example, watching more carefully for kidney artery aneurysms in TGFBR1 patients or screening more thoroughly for heart valve problems and neurological issues in SMAD3 patients. The findings reinforce the importance of comprehensive genetic testing for people diagnosed with LDS, as the specific mutation type appears to provide meaningful information about what complications to watch for over time.

Have a question about this study?

Citation

Nabi H, Dreher L, Hartnett J, Crossley A, El Ghandour H, Osundiji M, et al.. (2026). The Role of Genetic Variation in Phenotypic Variability in Loeys-Dietz Syndrome.. Human mutation. https://doi.org/10.1155/humu/2861205